Miami, Florida – The International Society for Stem Cell Application (ISSCA) is pleased to announce that an advanced training course on Functional Regenerative Medicine and Obesity will be held on October 13 and 14, 2024, at the Cellular Hope Institute in Cancun, Mexico. This two-day, immersive course aims to introduce healthcare professionals to innovative and integrative approaches to managing obesity, combining functional medicine and regenerative therapies.
Tackling a Global Health Crisis with New Approaches
With more than 650 million adults worldwide classified as obese, according to the World Health Organization (WHO), obesity has become one of the most urgent health challenges today. It not only increases the risk of chronic conditions such as cardiovascular disease and diabetes but also disrupts various bodily systems, contributing to metabolic dysfunction and inflammation. ISSCA’s upcoming training is designed to explore alternatives that go beyond conventional treatments, focusing on the root causes of obesity and offering patient-centered solutions.
Open to All Medical Specialties
The course is designed to be accessible to healthcare professionals across all specialties, as obesity can impact the function of multiple bodily systems. Whether practitioners are focused on primary care, regenerative medicine, or other fields, ISSCA believes that this training will provide valuable insights into how obesity-related issues can be addressed through functional and regenerative techniques.
Course Highlights: Topics and Training
- Non-Endoscopic Gastric Balloon Placement
Led by Dr. Mario Ojeda, this session will introduce non-invasive gastric balloon techniques that offer an alternative for managing obesity. Participants will explore patient assessment, technique, post-procedure care, and the importance of psychological and nutritional support. Live demonstrations and case studies will provide participants with practical, real-world knowledge. - Regenerative Therapies for Obesity and Inflammation
Dr. Silvina Pastrana will discuss how regenerative medicine may be used to support weight management by addressing underlying inflammation, a common contributor to obesity. Attendees will learn about the potential use of exosome-based treatments and peptide therapies such as semaglutide, tirzepatide, ipamorelin, and MOTS-C, which are emerging as alternatives in the field of metabolic regulation. - IV Therapy and Nutritional Supplementation
Attendees will also explore IV therapies that may enhance metabolic function and support weight management efforts. Dr. Pastrana will discuss detox drips, metabolic boosters, and antioxidants, and how these therapies could complement other treatments for patients struggling with obesity. - Functional Medicine and Gut Health
Dr. Andrea Marquez will focus on functional medicine’s role in treating obesity, emphasizing gut health and its connection to weight management. Topics will include insulin resistance, leaky gut syndrome, and common nutritional deficiencies. Attendees will learn how addressing these root causes could potentially lead to more effective and sustainable weight management strategies for patients.
A Holistic Approach to Patient Wellness
This course is expected to emphasize the importance of treating obesity through a comprehensive approach that addresses both metabolic function and overall patient wellness. ISSCA hopes that by incorporating regenerative medicine and functional treatments, healthcare providers can offer patients alternative, integrative solutions that target the root causes of obesity rather than relying on conventional methods alone.
Hands-On Experience and Certification
Participants will have the opportunity to engage in hands-on training sessions, including live demonstrations of non-invasive gastric balloon placement, IV therapies, and peptide treatments. At the conclusion of the course, attendees will receive a digital certificate of completion, along with access to recorded class videos and additional supporting documentation for ongoing reference.
A Step Toward New Solutions in Obesity Management
As obesity continues to rise globally, ISSCA aims to provide healthcare professionals with new strategies and alternatives that could help address this growing crisis. The Functional Regenerative Medicine and Obesity course is a step toward integrating holistic, patient-centered treatments into clinical practice.
About ISSCA
The International Society for Stem Cell Application (ISSCA) is a leading organization in the field of regenerative medicine. It is dedicated to advancing the science and practice of stem cell therapy and regenerative medicine through education, certification, research, and training. ISSCA provides certification training in cities worldwide, recognizing the importance of standards and certifications in regenerative medicine as a medical specialty.
ISSCA’s mission is to promote the benefits of stem cell medicine to patients globally, ensure the quality and uniformity of regenerative medicine practices, and establish itself as a global leader in the certification and education of medical professionals in this field. The organization is a distinguished division of the Global Stem Cells Group (GSCG) and has over 15 years of experience in the industry, making significant contributions to the advancement and dissemination of regenerative medicine knowledge and practices.
About Global Stem Cells Group
Global Stem Cells Group is a leading provider of regenerative medicine solutions, dedicated to advancing healthcare through innovative therapies. With a global presence and a multidisciplinary team of experts, the organization strives to harness the potential of stem cells and regenerative medicine to improve patient outcomes across various medical fields. Through its extensive network of clinics, research facilities, and training centers, Global Stem Cells Group is committed to pushing the boundaries of regenerative medicine and making a positive impact on global healthcare.
Global Stem Cells Group is a publicly traded company operating under the symbol MSSV. https://finance.yahoo.com/quote/mssv/
To learn more about Global Stem Cells Group, Inc.’s companies visit our website www.stemcellsgroup.com or call +1 305 560 5331
Safe Harbor Statement: Statements in this news release may be “forward-looking statements”. Forward-looking statements include, but are not limited to, statements that express our intentions, beliefs, expectations, strategies, predictions, or any other information relating to our future activities or other future events or conditions. These statements are based on current expectations, estimates, and projections about our business based partly on assumptions made by management. These statements are not guarantees of future performance and involve risks, uncertainties, and assumptions that are difficult to predict. Therefore, actual outcomes and results may and are likely to differ materially from what is expressed or forecasted in forward-looking statements due to numerous factors. Any forward-looking statements speak only as of the date of this news release, and The Global Stem Cells Group undertakes no obligation to update any forward-looking statement to reflect events or circumstances after the date of this news release. This press release does not constitute a public offer of any securities for sale. Any securities offered privately will not be or have not been registered under the Act and may not be offered or sold in the United States absent registration or an applicable exemption from registration requirements.
